NFE2L2 and Alzheimer disease: Particularly, RV significantly increased CAT, NFE2L2, and SOD2 in both HC and AD LCLs, whereas the change in expression of GSTZ1 and TXNIP did not reach significance according to Tukey’s post hoc tests (CAT: HC or AD control vs. HC or AD RV p < 0.0001; NFE2L2: HC or AD control vs. HC or AD RV p < 0.01; SOD2: HC control vs. HC RV p < 0.05, AD control vs. AD RV p < 0.01).